First-Line Therapy in Thoracic Oncology
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 15 October 2025 | Viewed by 1835
Special Issue Editors
Interests: lung cancer; thoracic oncology; tracheal surgery; airway surgery; mediastinal tumors
Interests: brochovascular reconstruction; lung cancer; pulmonary artery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Thoracic neoplasms include a heterogeneous group of diseases requiring multidisciplinary interaction for diagnosis and treatment. Lung cancer is surely the leading cause of cancer-related deaths worldwide. Over the last decades, significant advancements have been achieved in managing these tumors, especially when considering diagnostic tools for staging and restaging, integrated oncological protocols and refinements in surgical technique. Progresses in surgical approach have included minimally invasive procedures and increasing experience with more extended reconstructive operations.
The aim of this Special Issue, “First-Line Therapy in Thoracic Oncology” will focus on some of the main diagnostic and therapeutic aspects in thoracic oncology, to highlight topics from the perspective of different specialties involved in this field.
We invite you to contribute with an original article or a review article dealing with a topic in the research area of Thoracic Oncology. The information of this Special Issue is listed above. Let us know if you are interested providing a title for your contribution.
We look forward to receiving your contributions.
Dr. Antonio D'Andrilli
Dr. Giulio Maurizi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- thoracic oncology
- lung cancer
- thymoma
- mediastinal tumors
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
